Net Income

A new white paper details how the BioShare platform helps research institutions navigate the NIH's complex and costly new cybersecurity requirements.

Nano Dimension sells its AME product line to cut costs, while buyer Inspira Technologies makes a high-risk pivot from medical devices to quantum computing.

For decades, toxic chemicals were the norm in HVACR. See how one family business's commitment to safety led to explosive growth and industry-wide change.

Axe Compute names Kyle Okamoto President, a strategic hire signaling a major push to solve the AI 'distribution problem' and challenge hyperscaler dominance.

The 6th-gen Toyota RAV4 ditches gas engines, betting its all-hybrid lineup and new tech can keep it on top of the hyper-competitive small SUV market.

OFA Group announced a landmark $15M deal to tokenize a $1B NYC project, but its stock plummeted. What's behind this perplexing market disconnect?

Newsweek names Bloom Energy a top trustworthy company. We explore how 25 years of reliability, investor confidence, and market demand are shaping its future.

Following its major business combination, FuboTV has unveiled ambitious financial targets, signaling a dramatic shift from rapid growth to profitability.

dōTERRA's foundation is aiding Hawaiʻi flood victims with emergency kits, hygiene products, and a $25,000 donation match in partnership with Lāhui Foundation.

Decoy Therapeutics touts a revolutionary AI platform for multi-virus drugs, but faces financial hurdles. An upcoming investor event could define its future.

Enlyte's acquisition of PartsTrader signals a major shift in the auto claims industry, promising more efficiency but raising questions about competition.

The indoor air quality giant launches its roadshow, seeking to pay down debt and capitalize on soaring demand for healthier buildings and AI infrastructure.

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

New data shows companies working with CEO Coaching International are seeing revenue and profit growth that nearly doubles and triples U.S. market averages.

CanTex Capital's landmark sale of a 1.3M sq ft portfolio to Partners Group highlights booming demand for DFW's strategic shallow bay industrial assets.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

At AAN 2026, SK Life Science will present new cenobamate data and survey findings that expose a critical communication gap in epilepsy care.

A long-acting ketamine injection shows promise in treating severe depression without the harsh side effects and monitoring, potentially expanding access for millions.